Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

S.S. Soedamah-Muthu, Shona J. Livingstone, Valentine Charlton-menys, D. John Betteridge, Graham A. Hitman, H. Andrew W. Neil, Weihang Bao, David A. Demicco, Gregory M. Preston, John H. Fuller, Coen D. A. Stehouwer, Casper G. Schalkwijk, Paul N. Durrington, Helen M. Colhoun

Research output: Contribution to journalArticleScientificpeer-review

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)1494-1502
JournalDiabetologia
Volume58
Issue number7
DOIs
Publication statusPublished - 1 Jul 2015
Externally publishedYes

Cite this

Soedamah-Muthu, S. S., Livingstone, S. J., Charlton-menys, V., Betteridge, D. J., Hitman, G. A., Neil, H. A. W., Bao, W., Demicco, D. A., Preston, G. M., Fuller, J. H., Stehouwer, C. D. A., Schalkwijk, C. G., Durrington, P. N., & Colhoun, H. M. (2015). Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial. Diabetologia, 58(7), 1494-1502. https://doi.org/10.1007/s00125-015-3586-8